AIDS: MODERN CONCEPTS AND THERAPEUTIC CHALLENGES NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS: MODERN CONCEPTS AND THERAPEUTIC CHALLENGES

AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, 369 p., 1987.. Unique Identifier : AIDSLINE ICDB/89650434
Anonymous; No affiliation given

Abstract: Molecular, biological, epidemiological, psychosocial, and clinical features of AIDS and its related diseases are reviewed. Chapters cover the following topics: the biological basis of adult T-cell leukemia/lymphoma and AIDS (human T-lymphotropic retroviruses [HTLV-I, II, and III]), lymphadenopathy/AIDS virus as the prototype human lentivirus, molecular biology of the HTLV family, molecular biology of HTLV-III, animal models of HTLV-III/lymphadenopathy-associated virus (LAV) infection and AIDS, AIDS as a new kind of immunodeficiency, epidemiology of human retroviruses and related clinical conditions, psychiatric and psychosocial aspects of AIDS, spectrum of HTLV-III infection, pathology of AIDS, infectious complications of AIDS, an overview of classical and epidemic forms of Kaposi's sarcoma (KS), KS in the setting of the AIDS pandemic, AIDS-related malignant B-cell lymphomas, approaches to diagnosis and outcome assessment in pediatric AIDS, HTLV-III/LAV-related neurological disease, dermatological (non-KS) manifestations associated with HTLV-III/LAV infection, rapid in vitro systems for assessing activity of agents against HTLV-III/LAV, and strategies for pharmacological intervention against HTLV-III/LAV.
Keywords: Acquired Immunodeficiency Syndrome/DRUG THERAPY/*GENETICS Animal Antiviral Agents/THERAPEUTIC USE Cytopathogenic Effect, Viral/DRUG EFFECTS Human HIV/DRUG EFFECTS/*GENETICS MONOGRAPH

KWDacquiredimmunodeficiencysyndrome/drugtherapy/KWDgeneticsanimalantiviralagents/therapeuticusecytopathogeniceffect,viral/drugeffectshumanhiv/drugeffects/KWDgeneticsmonograph
890530
M8950704

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .